Lamictal Drug Buyers Lose Another Class Certification Bid
A proposed class of drug wholesalers accusing GlaxoSmithKline PLC and Teva Pharmaceuticals Ltd. of suppressing the generic competition to the epilepsy treatment and mood stabilizer Lamictal has failed to convince a...To view the full article, register now.
Already a subscriber? Click here to view full article